WallStreetZenWallStreetZen

NASDAQ: SMLR
Semler Scientific Inc Stock

$27.46+1.94 (+7.6%)
Updated Oct 11, 2024
SMLR Price
$27.46
Fair Value Price
N/A
Market Cap
$195.89M
52 Week Low
$20.88
52 Week High
$53.38
P/E
11.84x
P/B
2.5x
P/S
3.87x
PEG
1.09x
Dividend Yield
N/A
Revenue
$61.74M
Earnings
$15.82M
Gross Margin
88.7%
Operating Margin
30.35%
Profit Margin
25.6%
Debt to Equity
0.08
Operating Cash Flow
$20M
Beta
0.99
Next Earnings
Nov 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SMLR Overview

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SMLR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SMLR ($27.46) is trading above its intrinsic value of $22.52, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SMLR is good value based on its earnings relative to its share price (11.84x), compared to the US market average (27.31x)
P/E vs Market Valuation
SMLR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more SMLR due diligence checks available for Premium users.

Be the first to know about important SMLR news, forecast changes, insider trades & much more!

SMLR News

Valuation

SMLR fair value

Fair Value of SMLR stock based on Discounted Cash Flow (DCF)
Price
$27.46
Fair Value
$83.31
Undervalued by
67.04%
SMLR ($27.46) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SMLR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
11.84x
Industry
42.12x
Market
27.31x
SMLR is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SMLR is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

SMLR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.5x
Industry
4.07x
SMLR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SMLR price to earnings growth (PEG)

For valuing profitable companies with growth potential
SMLR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

SMLR's financial health

Profit margin

Revenue
$14.5M
Net Income
$11.0k
Profit Margin
0.1%
SMLR's Earnings (EBIT) of $18.74M... subscribe to Premium to read more.
Interest Coverage Financials
SMLR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$84.8M
Liabilities
$6.4M
Debt to equity
0.08
SMLR's short-term assets ($23.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SMLR's short-term assets ($23.69M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SMLR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SMLR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$4.9M
Investing
-$60.5M
Financing
$111.0k
SMLR's operating cash flow ($19.83M)... subscribe to Premium to read more.
Debt Coverage Financials

SMLR vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
SMLR$195.89M+7.60%11.84x2.50x
ELMD$195.84M+1.61%37.78x4.40x
NPCE$192.99M+6.44%-6.12x19.52x
SENS$189.59M+7.27%-2.72x328.02x
PROF$188.27M+2.81%-8.76x6.67x

Semler Scientific Stock FAQ

What is Semler Scientific's quote symbol?

(NASDAQ: SMLR) Semler Scientific trades on the NASDAQ under the ticker symbol SMLR. Semler Scientific stock quotes can also be displayed as NASDAQ: SMLR.

If you're new to stock investing, here's how to buy Semler Scientific stock.

What is the 52 week high and low for Semler Scientific (NASDAQ: SMLR)?

(NASDAQ: SMLR) Semler Scientific's 52-week high was $53.38, and its 52-week low was $20.88. It is currently -48.56% from its 52-week high and 31.51% from its 52-week low.

How much is Semler Scientific stock worth today?

(NASDAQ: SMLR) Semler Scientific currently has 7,133,788 outstanding shares. With Semler Scientific stock trading at $27.46 per share, the total value of Semler Scientific stock (market capitalization) is $195.89M.

Semler Scientific stock was originally listed at a price of $6.99 in Feb 21, 2014. If you had invested in Semler Scientific stock at $6.99, your return over the last 10 years would have been 292.85%, for an annualized return of 14.66% (not including any dividends or dividend reinvestments).

How much is Semler Scientific's stock price per share?

(NASDAQ: SMLR) Semler Scientific stock price per share is $27.46 today (as of Oct 11, 2024).

What is Semler Scientific's Market Cap?

(NASDAQ: SMLR) Semler Scientific's market cap is $195.89M, as of Oct 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Semler Scientific's market cap is calculated by multiplying SMLR's current stock price of $27.46 by SMLR's total outstanding shares of 7,133,788.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.